GUJARAT THEMIS BIOSYN LTD (GUJTHEM) financials

GUJARAT THEMIS BIOSYN LTD (GUJTHEM) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1981, Gujarat Themis BiosynLtd manufactures and sells finished Active Pharmaceutical Ingredients products by fermentation process[1]

Market Cap: ₹4,860Cr.
Current Price: ₹373
Stock P/E: 99.8
ROE: 17.4%
ROCE: 18.1%
Book Value: ₹26.4
Dividend Yield: 0.18%
52W High / Low: ₹479/225

In Jun 2026, GUJARAT THEMIS BIOSYN LTD (GUJTHEM) reported sales ₹44 Cr and net profit ₹11 Cr.

Annual TTM: sales ₹174 Cr, net profit ₹49 Cr.

Shareholding: Promoters 59.33% (Aug 2026), FIIs 4.93% (Aug 2026), DIIs 13.79% (Aug 2026), Public 21.95% (Aug 2026), No. of Shareholders 26,899% (Aug 2026).

GUJTHEM quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	35	40	38	36	42	43	44	44
Expenses	19	21	22	22	21	22	25	23
Operating Profit	15	19	16	14	21	21	19	21
OPM %	44%	48%	42%	39%	49%	49%	44%	48%
Other Income	0	0	1	0	1	0	1	0
Interest	0	0	0	0	0	1	2	2
Depreciation	1	2	1	2	3	4	4	4
Profit before tax	14	17	16	12	19	17	14	15
Tax %	26%	25%	25%	25%	24%	26%	24%	27%
Net Profit	11	13	12	9	14	12	11	11
EPS in Rs	0.97	1.19	1.10	0.83	1.31	1.14	1.00	1.02
Raw PDF	—	—	—	—	—	—	—	—

GUJTHEM profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	85	91	115	148	170	151	166	174
Expenses	53	50	57	75	91	82	89	91
Operating Profit	32	40	58	74	79	69	76	82
OPM %	37%	45%	51%	50%	46%	46%	46%	47%
Other Income	2	3	4	7	4	2	2	2
Interest	1	1	1	0	0	0	4	5
Depreciation	1	2	2	3	4	5	13	15
Profit before tax	31	41	59	77	79	66	62	65
Tax %	24%	26%	26%	25%	25%	26%	25%	—
Net Profit	24	30	44	58	59	49	47	49
EPS in Rs	2.17	2.77	4.00	5.32	5.43	4.48	4.28	4.47
Dividend Payout %	10%	0%	37%	14%	12%	15%	16%	—

GUJTHEM balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	7	7	7	7	7	7	11	11
Reserves	11	35	63	96	142	194	237	277
Borrowings	6	8	5	1	0	3	30	162
Other Liabilities	8	14	14	18	17	17	22	54
Total Liabilities	33	64	88	122	166	221	301	503
Fixed Assets	15	17	19	19	33	38	41	289
CWIP	1	0	2	13	21	91	184	121
Investments	0	0	0	0	0	0	0	0
Other Assets	17	47	67	90	113	92	76	93
Total Assets	33	64	88	122	166	221	301	503

GUJTHEM cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	1	1	11	40	39	64	91	49
Cash from Investing Activity	-6	-3	-2	-30	-20	-55	-112	-172
Cash from Financing Activity	5	2	-5	-14	-13	-9	26	115
Net Cash Flow	0	-0	3	-4	6	0	5	-9
Free Cash Flow	-5	-3	7	26	16	-10	-25	-124
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	25%	24%	51%	94%	81%	107%	156%	78%

GUJTHEM shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Aug 2026
Promoters	70.87%	70.87%	70.87%	70.87%	70.87%	70.86%	70.87%	59.33%
FIIs	1.42%	1.91%	2.51%	2.95%	1.96%	1.80%	1.76%	4.93%
DIIs	1.17%	1.17%	1.17%	1.17%	1.17%	1.17%	1.17%	13.79%
Public	26.55%	26.05%	25.44%	25.01%	26.00%	26.15%	26.18%	21.95%
No. of Shareholders	30,934	30,673	28,945	28,319	27,325	26,886	27,010	26,899

GUJTHEM key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	52	87	59	80	44	58	76	134
Inventory Days	—	194	144	255	201	33	75	263
Days Payable	—	240	84	145	131	99	218	625
Cash Conversion Cycle	52	41	119	189	114	-7	-67	-228
Working Capital Days	-58	42	80	155	91	50	46	8
ROCE %	45%	84%	67%	67%	61%	45%	27%	18%

GUJTHEMUpdated 18 Oct 2026, 16:05

Gujarat Themis Biosyn Ltd

GUJTHEMUpdated 18 Oct 2026, 16:05

Market Cap

₹4,860Cr.

Current Price

₹373

High / Low

₹479/225

Stock P/E

99.8

ROE17.4%

ROCE18.1%

Book Value₹26.4

Face Value₹1.00

Dividend Yield0.18%

About

Incorporated in 1981, Gujarat Themis BiosynLtd manufactures and sells finished Active Pharmaceutical Ingredients products by fermentation process[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	50	0	26	1	1	24	26	18	1.63
Sep 2023	40	0	23	1	1	17	26	13	1.15
Dec 2023	39	0	21	1	1	18	26	13	1.19
Mar 2024	42	0	21	1	1	21	24	16	1.46
Jun 2024	39	0	20	1	1	18	26	13	1.21
Sep 2024	35	0	19	0	1	14	26	11	0.97
Dec 2024	40	0	21	0	2	17	25	13	1.19
Mar 2025	38	0	22	1	1	16	25	12	1.1
Jun 2025	36	0	22	0	2	12	25	9	0.83
Sep 2025	42	0	21	1	3	19	24	14	1.31
Dec 2025	43	1	22	0	4	17	26	12	1.14
Mar 2026	44	2	25	1	4	14	24	11	1
Jun 2026	44	2	23	0	4	15	27	11	1.02

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	31	0	25	0	1	5	0	5	0.42
Mar 2016	33	0	27	0	1	5	0	5	0.42
Mar 2017	36	0	30	0	1	5	10	4	0.4
Mar 2018	39	0	33	0	1	5	20	4	0.36
Mar 2019	41	0	34	2	1	8	22	6	0.59
Mar 2020	85	1	53	2	1	31	24	24	2.17
Mar 2021	91	1	50	3	2	41	26	30	2.77
Mar 2022	115	1	57	4	2	59	26	44	4
Mar 2023	148	0	75	7	3	77	25	58	5.32
Mar 2024	170	0	91	4	4	79	25	59	5.43
Mar 2025	151	0	82	2	5	66	26	49	4.48
Mar 2026	166	4	89	2	13	62	25	47	4.28
TTM	174	5	91	2	15	65	—	49	4.47

Shareholding pattern

As of Aug 2026%

Holder	Share
Promoters	59.33%
FIIs	4.93%
DIIs	13.79%
Public	21.95%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	70.87%	0.86%	0.04%	28.23%
Mar 2024	70.87%	1.05%	0.82%	27.26%
Jun 2024	70.87%	1.44%	1.18%	26.52%
Sep 2024	70.87%	1.49%	1.17%	26.47%
Dec 2024	70.87%	1.42%	1.17%	26.55%
Mar 2025	70.87%	1.91%	1.17%	26.05%
Jun 2025	70.87%	2.51%	1.17%	25.44%
Sep 2025	70.87%	2.95%	1.17%	25.01%
Dec 2025	70.87%	1.96%	1.17%	26%
Mar 2026	70.86%	1.8%	1.17%	26.15%
Jun 2026	70.87%	1.76%	1.17%	26.18%
Aug 2026	59.33%	4.93%	13.79%	21.95%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Other Assets	Total Assets
Mar 2015	7	-8	6	9	15	10	0	5	15
Mar 2016	7	-3	3	8	15	9	0	5	15
Mar 2017	7	1	4	9	21	11	0	11	21
Mar 2018	7	5	1	8	20	11	0	10	20
Mar 2019	7	11	6	8	33	15	1	17	33
Mar 2020	7	35	8	14	64	17	0	47	64
Mar 2021	7	63	5	14	88	19	2	67	88
Mar 2022	7	96	1	18	122	19	13	90	122
Mar 2023	7	142	0	17	166	33	21	113	166
Mar 2024	7	194	3	17	221	38	91	92	221
Mar 2025	11	237	30	22	301	41	184	76	301
Mar 2026	11	277	162	54	503	289	121	93	503

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	3	0	-3	-1
Mar 2016	4	-1	-3	0
Mar 2017	3	-3	0	0
Mar 2018	6	-1	-4	1
Mar 2019	1	-6	5	0
Mar 2020	1	-3	2	0
Mar 2021	11	-2	-5	3
Mar 2022	40	-30	-14	-4
Mar 2023	39	-20	-13	6
Mar 2024	64	-55	-9	0
Mar 2025	91	-112	26	5
Mar 2026	49	-172	115	-9

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	28	24	71	26	52	87	59	80	44	58	76	134
Inventory Days	—	—	—	78	—	194	144	255	201	33	75	263
Days Payable	—	—	—	947	—	240	84	145	131	99	218	625
Cash Conversion Cycle	28	24	71	-844	52	41	119	189	114	-7	-67	-228
Working Capital Days	-76	-70	-42	-43	-58	42	80	155	91	50	46	8
ROCE %	121%	81%	55%	42%	45%	84%	67%	67%	61%	45%	27%	18%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of GUJARAT THEMIS BIOSYN LTD (GUJTHEM)?

The reported market capitalisation for GUJARAT THEMIS BIOSYN LTD (GUJTHEM) is ₹4,860Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of GUJTHEM?

The current price shown for GUJARAT THEMIS BIOSYN LTD (GUJTHEM) on Fincrux is ₹373 with a 52-week high/low of ₹479/225.

What is the P/E ratio of GUJARAT THEMIS BIOSYN LTD (GUJTHEM)?

The stock P/E for GUJARAT THEMIS BIOSYN LTD (GUJTHEM) is 99.8 on Fincrux, with ROE at 17.4% and ROCE at 18.1%.

What were GUJTHEM latest quarterly results?

For Jun 2026, GUJARAT THEMIS BIOSYN LTD (GUJTHEM) reported sales ₹44 Cr and net profit ₹11 Cr (figures in ₹ crore unless noted).

What are GUJTHEM annual sales and net profit?

For TTM, GUJARAT THEMIS BIOSYN LTD (GUJTHEM) shows sales of ₹174 Cr and net profit of ₹49 Cr on the Fincrux profit & loss statement.

Who owns GUJARAT THEMIS BIOSYN LTD (GUJTHEM)?

Latest shareholding for GUJARAT THEMIS BIOSYN LTD (GUJTHEM) on Fincrux: Promoters 59.33% (Aug 2026), FIIs 4.93% (Aug 2026), DIIs 13.79% (Aug 2026), Public 21.95% (Aug 2026), No. of Shareholders 26,899% (Aug 2026).

Where can I find GUJARAT THEMIS BIOSYN LTD (GUJTHEM) financials?

GUJARAT THEMIS BIOSYN LTD (GUJTHEM) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show GUJTHEM balance sheet and cash flow?

Yes. The GUJARAT THEMIS BIOSYN LTD (GUJTHEM) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 16:05